Live feed
Filing
SC 13G
SC 13G0001193125-24-088525·GILEAD SCIENCES, INC.
Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Security class unavailable · CUSIP: 98422T100
Event date: 2024-03-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-088525
- Form type
- SC 13G
- Filer
- GILEAD SCIENCES, INC.
- CIK
- CIK 882095
- Filed
- Apr 05, 2024
- Reporting period
- Mar 27, 2024
- Description
- Schedule 13G beneficial ownership